Solid lipid nanoparticles: a review on recent perspectives and patents

References

• Paliwal R, Rai S, Vaidya B, et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine: Nanotechnology, Biology and Medicine. 2009;5(2):184–191.
   PubMed Web of Science ®Google Scholar
• Cortesi R, Esposjto E, Luca G, et al. Production of lipospheres as carriers for bioactive compounds. Biomaterials. 2002;23:2283–2294.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Paliwal SR, Agrawal GP, et al. Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation. Mol Pharm. 2011;8(4):1314–1321.
   PubMed Web of Science ®Google Scholar
• Vyas SP, Rai S, Paliwal R, et al. Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: one step up in nanotechnology. Curr Nanosci. 2008;4(1):30–44.
   Web of Science ®Google Scholar
• Battaglia L, Serpe L, Muntoni E, et al. Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution. Nanomedicine. 2011;6(9):1561–1573.
   PubMed Web of Science ®Google Scholar
• Jain SK, Chaurasiya A, Gupta Y, et al. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting. J Microencapsul. 2008;25(5):289–297.
   PubMed Web of Science ®Google Scholar
• Essaghraoui A, Belfkira A, Hamdaoui B, et al. Improved dermal delivery of cyclosporine a loaded in solid lipid nanoparticles. Nanomaterials. 2019;9(9):1204.
   Web of Science ®Google Scholar
• Shilpi S, Vimal VD, Soni V. Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung. Prog Biomater. 2015;4(1):55–63.
   PubMed Web of Science ®Google Scholar
• Valdes SA, Alzhrani RF, Rodriguez A, et al. A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine with increased solubility, stability, and antitumor activity. Int J Pharm. 2019;12:118609.
   Google Scholar
• Esposito E, Sguizzato M, Drechsler M, et al. Lipid nanostructures for antioxidant delivery: a comparative preformulation study. Beilstein J Nanotechnol. 2019;10(1):1789–1801.
   PubMedGoogle Scholar
• Garg NK, Singh B, Jain A, et al. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. Colloids Surf B Biointerfaces. 2016;146:114–126.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vyas SP. Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate. J Biomed Nanotechnol. 2011;7(1):130–131.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Park JW, Yoon IS, et al. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomedicine. 2014;9:495–504.
   PubMed Web of Science ®Google Scholar
• Du B, Yan Y, Li Y, et al. Preparation and passive target of 5-fluorouracil solid lipid nanoparticles. Pharm Dev Technol. 2010;15(4):346–353.
   PubMed Web of Science ®Google Scholar
• Pandey R, Sharma S, Khuller GK. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis. 2005;85(5–6):415–420.
   PubMed Web of Science ®Google Scholar
• Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul. 2001;18(2):149–158.
   PubMed Web of Science ®Google Scholar
• Padois K, Cantieni C, Bertholle V, et al. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil. Int J Pharm. 2011;416(1):300–304.
   PubMedGoogle Scholar
• Wosicka-Frackowiak H, Cal K, Stefanowska J, et al. Roxithromycin-loaded lipid nanoparticles for follicular targeting. Int J Pharm. 2015;495(2):807–815.
   PubMed Web of Science ®Google Scholar
• Talpur R, Cox K, Duvic M. Efficacy and safety of topical tazarotene: a review. Expert Opin Drug Metab Toxicol. 2009;5(2):195–210.
   PubMed Web of Science ®Google Scholar
• Souto EB, Doktorovova S, Gonzalez-Mira E, et al. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs. Curr Eye Res. 2010;35(7):537–552.
   PubMed Web of Science ®Google Scholar
• Kakkar V, Kaur IP. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol. 2011;49(11):2906–2913.
   PubMed Web of Science ®Google Scholar
• Kakkar V, Singh S, Singla D, et al. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res. 2011;55(3):495–503.
   PubMed Web of Science ®Google Scholar
• Qi C, Chen Y, Huang JH, et al. Preparation and characterization of catalase-loaded solid lipid nanoparticles based on soybean phosphatidylcholine. J Sci Food Agric. 2012;92(4):787–793.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004;56(9):1257–1272.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009 Jul;71(4):349–358.
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161–177.
   PubMed Web of Science ®Google Scholar
• Marengo E, Cavalli R, Caputo O, et al. Scale-up of the preparation process of solid lipid nanospheres part I. Int J Pharm. 2000;205(1–2):3–13.
   PubMedGoogle Scholar
• Rostamabadi H, Falsafi SR, Jafari SM. Nanoencapsulation of carotenoids within lipid-based nanocarriers. J Control Release. 2019;298:38–67.
   PubMed Web of Science ®Google Scholar
• Anand A, Sugumaran A, Narayanasamy D. Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles. IET Nanobiotechnol. 2019;13(4):353–362.
   PubMed Web of Science ®Google Scholar
• Talegaonkar S, Bhattacharyya A. Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability. AAPS PharmSciTech. 2019;20(3):121.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Pillai J. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs. Expert Opin Drug Metab Toxicol. 2019;15:499–515.
   PubMed Web of Science ®Google Scholar
• da Silva Santos V, Ribeiro AP, Santana MH. Solid lipid nanoparticles as carriers for lipophilic compounds for applications in foods. Food Res Int. 2019;122:610–626.
   Web of Science ®Google Scholar
• Hsu CY, Wang PW, Alalaiwe A, et al. Use of lipid nanocarriers to improve oral delivery of vitamins. Nutrients. 2019;11(1):68.
   PubMed Web of Science ®Google Scholar
• Bayón-Cordero L, Alkorta I, Arana L. Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs. Nanomaterials. 2019;9(3):474.
   Web of Science ®Google Scholar
• Garces A, Amaral MH, Sousa Lobo JM, et al. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. Eur J Pharm Sci. 2018;112:159–167.
   PubMed Web of Science ®Google Scholar
• Amoabediny G, Haghiralsadat F, Naderinezhad S, et al. Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: a comprehensive review. Int J Polym Mater. 2018;67(6):383–400.
   Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.
   PubMed Web of Science ®Google Scholar
• Khosa A, Reddi S, Saha RN. Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother. 2018;103:598–613.
   PubMed Web of Science ®Google Scholar
• Lin CH, Chen CH, Lin ZC, et al. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. J Food Drug Anal. 2017;25(2):219–234.
   PubMed Web of Science ®Google Scholar
• Shastri DH. Effective delivery routes and strategies for Solid lipid nanoparticles (SLN) and Nanostructured lipid carriers (NLC). Curr Pharm Des. 2017;23(43):6592–601.
   Web of Science ®Google Scholar
• Nunes S, Madureira AR, Campos D, et al. Solid lipid nanoparticles as oral delivery systems of phenolic compounds: overcoming pharmacokinetic limitations for nutraceutical applications. Crit Rev Food Sci Nutr. 2017;57(9):1863–1873.
   PubMed Web of Science ®Google Scholar
• Tapeinos C, Battaglini M, Ciofani G. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. J Control Release. 2017;264:306–332.
   PubMed Web of Science ®Google Scholar
• Talluri SV, Kuppusamy G, Karri VV, et al. Lipid-based nanocarriers for breast cancer treatment - comprehensive review. Drug Deliv. 2016;23(4):1291–1305.
   PubMed Web of Science ®Google Scholar
• Geszke-Moritz M, Moritz M. Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies. Mater Sci Eng C Mater Biol Appl. 2016;68:982–994.
   PubMed Web of Science ®Google Scholar
• Dolatabadi JE, Valizadeh H, Hamishehkar H. Solid lipid nanoparticles as efficient drug and gene delivery systems: recent breakthroughs. Adv Pharm Bull. 2015;5(2):151.
   PubMed Web of Science ®Google Scholar
• Lauterbach A, Muller-Goymann CC. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route. Eur J Pharm Biopharm. 2015;97(Pt A):152–163.
   PubMedGoogle Scholar
• Wang Y, Rajala A, Rajala RV. Lipid nanoparticles for ocular gene delivery. J Funct Biomater. 2015;6(2):379–394.
   PubMed Web of Science ®Google Scholar
• Nasr M, Abdel-Hamid S, Alyoussef AA. A highlight on lipid based nanocarriers for transcutaneous immunization. Curr Pharm Biotechnol. 2015;16(4):371–379.
   PubMed Web of Science ®Google Scholar
• De Jesus MB, Zuhorn IS. Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms. J Control Release. 2015;201:1–13.
   PubMed Web of Science ®Google Scholar
• Morales JO, Valdes K, Morales J, et al. Lipid nanoparticles for the topical delivery of retinoids and derivatives. Nanomedicine. 2015;10(2):253–269.
   PubMed Web of Science ®Google Scholar
• Khan S, Baboota S, Ali J, et al. Nanostructured lipid carriers: an emerging platform for improving oral bioavailability of lipophilic drugs. Int J Pharm Investig. 2015;5(4):182–191.
   PubMed Web of Science ®Google Scholar
• Rostami E, Kashanian S, Azandaryani AH, et al. Drug targeting using solid lipid nanoparticles. Chem Phys Lipids. 2014;181:56–61.
   PubMed Web of Science ®Google Scholar
• Carbone C, Cupri S, Leonardi A, et al. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization. Pharm Pat Anal. 2013;2(5):665–677.
   PubMedGoogle Scholar
• Battaglia L, Gallarate M. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv. 2012;9(5):497–508.
   PubMed Web of Science ®Google Scholar
• Attama AASLN, NLC LDC. state of the art in drug and active delivery. Recent Pat Drug Deliv Formul. 2011;5(3):178–187.
   PubMedGoogle Scholar
• Corrias F, Lai F. New methods for lipid nanoparticles preparation. Recent Pat Drug Deliv Formul. 2011;5(3):201–213.
   PubMedGoogle Scholar
• Bunjes H. Lipid nanoparticles for the delivery of poorly water-soluble drugs. J Pharm Pharmacol. 2010;62(11):1637–1645.
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Shaw J, Al-Kassas R. Solid lipid nanoparticles for ocular drug delivery. Drug Deliv. 2010;17(7):467–489.
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. InDrug delivery. 2010;197:115–141. Springer, Berlin, Heidelberg.
   Google Scholar
• Bondi ML, Craparo EF. Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art. Expert Opin Drug Deliv. 2010;7(1):7–18.
   PubMed Web of Science ®Google Scholar
• Sawant KK, Dodiya SS. Recent advances and patents on solid lipid nanoparticles. Recent Pat Drug Deliv Formul. 2008;2(2):120–135.
   PubMedGoogle Scholar
• Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 2007;59(6):478–490.
   PubMed Web of Science ®Google Scholar
• Silva AM, Martins-Gomes C, Fangueiro JF, et al. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines. Pharm Dev Technol. 2019;24(10):1243–1249.
   Web of Science ®Google Scholar
• Maithania HV, Mohanty BS, Chaudhari PR, et al. Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles. Drug Deliv Transl Res. 2020;10(1):159–167.
   PubMedGoogle Scholar
• Kondel R, Shafiq N, Kaur IP, et al. Effect of acyclovir solid lipid nanoparticles for treatment of Herpes Simplex Virus (HSV) infection in an animal model of HSV-1 infection. Pharm Nanotechnol. 2019;7:389–403.
   PubMedGoogle Scholar
• Kang JH, Chon J, Kim YI, et al. Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution. Int J Nanomedicine. 2019;14:5381.
   PubMed Web of Science ®Google Scholar
• Yu Z, Fan W, Wang L, et al. Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles. Biomater. Sci. 2019;7:4273–4282.
   Web of Science ®Google Scholar
• Ahangarpour A, Oroojan AA, Khorsandi L, et al. Hyperglycemia-induced oxidative stress in isolated proximal tubules of mouse: the in vitro effects of myricitrin and its solid lipid nanoparticle. Arch Insect Biochem Physiol. 2019;1–7.DOI: 10.1080/13813455.2019.1647250
   Google Scholar
• Gambhire VM, Gambhire MS, Ranpise NS. Solid lipid nanoparticles of dronedarone hydrochloride for oral delivery: optimization, in vivo pharmacokinetics and uptake studies. Pharm Nanotechnol. 2019;7:375–388.
   PubMedGoogle Scholar
• Kumar R, Singh A, Garg N. Acoustic cavitation-assisted formulation of solid lipid nanoparticles using different stabilizers. ACS Omega. 2019;4:13360–13370.
   Web of Science ®Google Scholar
• He J, Huang S, Sun X, et al. Carvacrol loaded solid lipid nanoparticles of propylene glycol monopalmitate and glyceryl monostearate: preparation, characterization, and synergistic antimicrobial activity. Nanomaterials. 2019;9(8):1162.
   Web of Science ®Google Scholar
• Dara T, Vatanara A, Sharifzadeh M, et al. Improvement of memory deficits in the rat model of alzheimer’s disease by erythropoietin-loaded solid lipid nanoparticles. Neurobiol Learn Mem. 2019;166:107082.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zheng Y, Wu L, et al. Novel solid lipid nanoparticle with endosomal escape function for oral delivery of insulin. ACS Appl Mater Interfaces. 2018;10(11):9315–9324.
   PubMed Web of Science ®Google Scholar
• Bhatt H, Rompicharla SVK, Komanduri N, et al. Development of curcumin-loaded solid lipid nanoparticles utilizing glyceryl monostearate as single lipid using QbD approach: characterization and evaluation of anticancer activity against human breast cancer cell line. Curr Drug Deliv. 2018;15:1271–1283.
   PubMed Web of Science ®Google Scholar
• Oliveira MS, Lima BHS, Goulart GAC, et al. Improved cytotoxic effect of doxorubicin by its combination with sclareol in solid lipid nanoparticle suspension. J Nanosci Nanotechnol. 2018;18(8):5609–5616.
   PubMed Web of Science ®Google Scholar
• Vijayakumar A, Baskaran R, Jang YS, et al. Quercetin-loaded solid lipid nanoparticle dispersion with improved physicochemical properties and cellular uptake. AAPS PharmSciTech. 2017;18(3):875–883.
   PubMed Web of Science ®Google Scholar
• Ji P, Yu T, Liu Y, et al. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug Des Devel Ther. 2016;10:911–925.
   PubMed Web of Science ®Google Scholar
• Lingling G, Yuan Z, Weigen L. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles. Drug Dev Ind Pharm. 2016;42(8):1325–1333.
   PubMed Web of Science ®Google Scholar
• Garanti T, Stasik A, Burrow AJ, et al. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles. Int J Pharm. 2016;500(1–2):305–315.
   PubMed Web of Science ®Google Scholar
• Rigon RB, Fachinetti N, Severino P, et al. Skin delivery and in vitro biological evaluation of trans-resveratrol-loaded solid lipid nanoparticles for skin disorder therapies. Molecules. 2016;21(1):E116.
   PubMed Web of Science ®Google Scholar
• Senel B B, lu G, et al. Solid lipid and chitosan particulate systems for delivery of siRNA. Pharmazie-. An Int J Pharm. 2015;70(11):698–705.
   Google Scholar
• Kuo YC, Lee CH. Dual targeting of solid lipid nanoparticles grafted with 83–14 MAb and anti-EGF receptor for malignant brain tumor therapy. Life Sci. 2016;146:222–231.
   PubMed Web of Science ®Google Scholar
• Kurakula M, Ahmed OA, Fahmy UA, et al. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. J Liposome Res. 2016;26(4):288–296.
   PubMed Web of Science ®Google Scholar
• Bhalekar MR, Upadhaya PG, Madgulkar AR. Fabrication and efficacy evaluation of chloroquine nanoparticles in CFA-induced arthritic rats using TNF-alpha ELISA. Eur J Pharm Sci. 2016;84:1–8.
   PubMed Web of Science ®Google Scholar
• Ravanfar R, Tamaddon AM, Niakousari M, et al. Preservation of anthocyanins in solid lipid nanoparticles: optimization of a microemulsion dilution method using the Placket-Burman and Box-Behnken designs. Food Chem. 2016;199:573–580.
   PubMed Web of Science ®Google Scholar
• Li JC, Zhang WJ, Zhu JX, et al. Preparation and brain delivery of nasal solid lipid nanoparticles of quetiapine fumarate in situ gel in rat model of schizophrenia. Int J Clin Exp Med. 2015;8(10):17590–17600.
   PubMed Web of Science ®Google Scholar
• Kuo YC, Wang IH. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles. J Drug Target. 2016;24(7):645–654.
   PubMed Web of Science ®Google Scholar
• Madureira AR, Campos DA, Oliveira A, et al. Insights into the protective role of solid lipid nanoparticles on rosmarinic acid bioactivity during exposure to simulated gastrointestinal conditions. Colloids Surf B Biointerfaces. 2016;139:277–284.
   PubMed Web of Science ®Google Scholar
• Oliveira MS, Aryasomayajula B, Pattni B, et al. Solid lipid nanoparticles co-loaded with doxorubicin and alpha-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models. Int J Pharm. 2016;512(1):292–300.
   PubMedGoogle Scholar
• Esmaeili M, Aghajani M, Abbasalipourkabir R, et al. Budesonide-loaded solid lipid nanoparticles for pulmonary delivery: preparation, optimization, and aerodynamic behavior. Artif Cells Nanomed Biotechnol. 2016;44(8):1964–1971.
   PubMed Web of Science ®Google Scholar
• Hamishehkar H, Same S, Adibkia K, et al. A comparative histological study on the skin occlusion performance of a cream made of solid lipid nanoparticles and Vaseline. Res Pharm Sci. 2015;10(5):378–387.
   PubMed Web of Science ®Google Scholar
• Kim S, Diab R, Joubert O, et al. Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin. Colloids Surf B Biointerfaces. 2016;140:161–168.
   PubMed Web of Science ®Google Scholar
• Aboud HM, El Komy MH, Ali AA, et al. Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery. AAPS PharmSciTech. 2016;17:1353–1365.
   PubMed Web of Science ®Google Scholar
• Omwoyo WN, Melariri P, Gathirwa JW, et al. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles. Nanomedicine. 2016;12:801–809.
   PubMed Web of Science ®Google Scholar
• Wadhwa S, Paliwal R, Paliwal SR, et al. Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des. 2009;15:2724–2750.
   PubMed Web of Science ®Google Scholar
• Baig MS, Ahad A, Aslam M, et al. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: optimization, in vitro release, ocular tolerance, and antibacterial activity. Int J Biol Macromol. 2016;85:258–270.
   PubMed Web of Science ®Google Scholar
• Gambhire VM, Salunkhe SM, Gambhire MS. Atorvastatin loaded lipid nanoparticles: antitumor activity studies on MCF-7 breast cancer cells. Drug Dev Ind Pharm. 2018;44(10):1685–1692.
   PubMed Web of Science ®Google Scholar
• Nakhlband A, Eskandani M, Saeedi N, et al. Marrubiin-loaded solid lipid nanoparticles’ impact on TNF-alpha treated umbilical vein endothelial cells: A study for cardioprotective effect. Colloids Surf B Biointerfaces. 2018;164:299–307.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang H, Yang W, et al. Improved oral bioavailability and liver targeting of sorafenib solid lipid nanoparticles in rats. AAPS PharmSciTech. 2018;19(2):761–768.
   PubMed Web of Science ®Google Scholar
• Makwana V, Jain R, Patel K, et al. Solid lipid nanoparticles (SLN) of efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm. 2015;495(1):439–446.
   PubMedGoogle Scholar
• Garg A, Singh S. Targeting of eugenol-loaded solid lipid nanoparticles to the epidermal layer of human skin. Nanomedicine. 2014;9(8):1223–1238.
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54(Suppl 1):S131–55.
   PubMed Web of Science ®Google Scholar
• Rao KK. Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides. US20080311214A1; 2008.
   Google Scholar
• Ferreira LAM, Goulart GAC, Orefice R, et al. Process to obtain a pharmaceutical composition of retinoids, derivative product of retinoids and its use. WO2009111852A2; 2008.
   Google Scholar
• Gasco MR. Use of solid lipid nanoparticles comprising cholesteryl propionate and/or cholesteryl butyrate. US20090306032A1; 2009.
   Google Scholar
• Padois K, Pirot F, Falson F. Solid lipid nanoparticles encapsulating minoxidil, and aqueous suspension containing same. WO2010112749A1; 2009.
   Google Scholar
• Zhiwen Z, Yaping L, Wang G, et al. Daidzein solid lipid nanoparticles and preparation method thereof. CN102258475B; 2010.
   Google Scholar
• Jun T, Dangguo W, Haitao G, et al. Solid lipid nanoparticles of finasteride and preparation method thereof. CN101559038B; 2011.
   Google Scholar
• Huang J, Chen Y, Wang X. Preparation method of catalase solid lipid nanoparticles preparation. CN101972229B; 2011.
   Google Scholar
• Zhou X, Wang J, Hu X. Glycyrrhetinic acid solid lipid nanoparticles and preparation method for same. CN102512369A; 2011.
   Google Scholar
• Tao L. Ranitidine hydrochloride/bismuth potassium citrate pharmaceutical composition solid lipid nanoparticles preparation. CN102697765B; 2012.
   Google Scholar
• Zhang Y, Han G, Du G, et al. Suspension containing Andrographolide solid lipid nanoparticles as well as preparation method and application of suspension. CN102716080B; 2012.
   Google Scholar
• Fengzhen W, Qing Z, Sun J et al. Chitosan-modified methazolamide solid lipid nanoparticles and preparation method thereof. CN102793672A; 2012.
   Google Scholar
• Park SM, Kim HR, Park JC, et al. Solid lipid nanoparticles including elastin-like polypeptides and use thereof. EP2623097B1; 2013.
   Google Scholar
• Chengcheng W, Yan M, Xia G. Solid lipid nanoparticles of alendronate sodium and preparation method thereof. CN103356506A; 2013.
   Google Scholar
• Xiaoqun G, Rong G, Weikang G, et al. Lactoferrin modified solid lipid nanoparticles, as well as preparation method and application thereof. CN20131499991; 2014.
   Google Scholar
• Kaur IP, Verma MK. Process for preparing solid sustained release nanoparticles for delivery of vitamins. US201314371338; 2014.
   Google Scholar
• Krysztof C, Hanna W. Solid lipid nanoparticles of roxithromycin for hair loss or acne. EP20130811630; 2014.
   Google Scholar
• Yanqing Z, Junbo X, Ting Z, et al. Spinosin solid lipid nanoparticles and preparation method and application thereof. CN103845307B; 2015.
   Google Scholar
• Jesudian GGJ, Vijaya C, Kaur IP. Topical tazarotene solid lipid nanoparticles. 149/CHE/2014; 2015.
   Google Scholar
• Baogang X, Huiyun W, Haipeng W, et al. Sorafenib solid lipid nanoparticles and preparation method thereof. CN105326812A; 2016.
   Google Scholar
• Wanping Z, Xiaomei Z, Xiaozhi L, et al. Nanostructured solid lipid carrier coating vitamin A palmitate and preparation method thereof. CN105496801A; 2016.
   Google Scholar
• Paliwal S, Paliwal R, Agrawal G, et al. Liposomal nanomedicine for breast cancer therapy. Nanomedicine. 2011;6:1085–1100.
   PubMed Web of Science ®Google Scholar
• Jingling T, Wu RJ, Hua L, et al. Curcumin and piperine carried solid lipid nanoparticles and preparation method thereof. CN103784421A; 2016.
   Google Scholar
• Chen Z, Shaoqiang L, Qingtao T, et al. Glabridin-cladded nano solid lipid carrier and preparation method and application thereof. CN105581911A; 2016.
   Google Scholar
• Paliwal SR, Paliwal R, Agrawal GP, et al. Targeted breast cancer nanotherapeutics: options and opportunities with estrogen receptors. Crit Rev Ther Drug Carrier Syst. 2012;29:421–446.
   PubMed Web of Science ®Google Scholar
• Lian Y, Lihua T, Yan Z, et al. Folic acid targeting silymarin solid lipid nanosphere preparation method. CN105708803A; 2016.
   Google Scholar
• Shilong W, Rongrong Z, Xiaolie H Application of solid lipid nanoparticles as antidepressant drug carrier. CN105919973A; 2016.
   Google Scholar
• Paliwal R, Babu RJ, Palakurthi S. Nanomedicine scale-up technologies: feasibilities and challenges. Aaps Pharmscitech. 2014;15:1527–1534.
   PubMed Web of Science ®Google Scholar
• Huaixiang T, Danfeng L, Jing H, et al. A kind of citral solid lipid nanoparticle under acid condition and preparation method thereof. CN106076213A; 2016.
   Google Scholar
• Zaixin C, Shujuan W, Xufang L, et al. A kind of composition for oral liquid of telmisartan and amlodipine and preparation method thereof. CN106822122A; 2017.
   Google Scholar
• Baogang X, Wei W, Haipeng W, et al. Alendronate sodium solid lipid nanoparticle and preparation method thereof. CN106821984A; 2017
   Google Scholar
• University of Mississippi, Repka MA, Patil HG, Majumdar S, et al. Systems and methods for preparing solid lipid nanoparticles. United States patent application US 15/128,536; 2017.
   Google Scholar
• Bum-kun K, Park PJ, Vessel C, et al. Nano-structured lipid carrier comprising α-tocopherol and preparing method thereof. KR 101777616B1; 2017.
   Google Scholar
• Hui ZC, Peach ZJ. Nanostructure lipid carrier coated with sun-screening agent and preparation method and application thereof. KR101799539B1; 2017.
   Google Scholar
• Jinki K, Hyungseo K, Jihye C, et al. Solid lipid nanoparticles composition comprising docetaxel for oral formulation. KR101799539B1; 2017.
   Google Scholar
• Ineb - National Institute Of Biomedical Engineering, University Of Porto, Seabra CL, Nunes CD, De Freitas M et al. Nanostructurated lipid carriers, methods and uses thereof. WO2018002853A1; 2018.
   Google Scholar
• Wook E, Hae-young J, Hyung-ryong M, et al. Solid lipid nanoparticles composition for skin-whitening effect comprising MHY498 and preparation method thereof. KR101860555B1; 2018.
   Google Scholar
• Young-tak K, Ramalingham P, Sang-woo Y. A liphophilic curcumin-loaded solid lipid nanoparticle surface-modified with chitosan. KR101871328B1; 2018.
   Google Scholar
• Southwest S, Young-sook S, Sun-kyu P. Cosmetic composition containing cordycepin stabilized by solid lipid nanoparticles. KR101870512B1; 2018.
   Google Scholar
• Lili Q, Jialei C, Songhui Y et al. Sports fatigue-resistant resveratrol solid lipid nanoparticles and preparation method thereof. CN108420801A; 2018.
   Google Scholar
• Yong H, Yonghao G, Zonghao W. Total bufadienolides solid lipid nanoparticle drug delivery system for injection and preparation method thereof. CN104997759A; 2018
   Google Scholar
• Gaillard PJ, Rip J. Pegylated lipid nanoparticle with bioactive lipophilic compound. United States patent application US 15/751,170. 2018.
   Google Scholar
• Capsugel, Diorio C, Lokhnauth J. Curcumin solid lipid particles and methods for their preparation and use. United States patent application. US10166187B2; 2019.
   Google Scholar
• Yongzhong D, Hui C, Chen Z. Salvianolate lipid nanoparticle and preparation method thereof. CN105902530A; 2019.
   Google Scholar
• Fox CB, Khandhar AP, Van Hoeven N, et al. Nanostructured lipid carriers and stable emulsions and uses thereof. WO2018232257A9; 2019.
   Google Scholar